
KKR and Ampersand Capital Partners have made a $400 million bid to acquire Oxford Immunotec Global Plc, reported Reuters. Oxford Immunotec is a medical diagnostics company that develops tests to identify tuberculosis.
Source: Reuters
KKR and Ampersand Capital Partners have made a $400 million bid to acquire Oxford Immunotec Global Plc, reported Reuters.
KKR and Ampersand Capital Partners have made a $400 million bid to acquire Oxford Immunotec Global Plc, reported Reuters. Oxford Immunotec is a medical diagnostics company that develops tests to identify tuberculosis.
Source: Reuters
Copyright PEI Media
Not for publication, email or dissemination